Does the Regulatory Environment for E-Cigarettes Influence the Effectiveness of E-Cigarettes for Smoking Cessation?: Longitudinal Findings From the ITC Four Country Survey

Grants

Funding Acknowledgements

The ITC Four Country Survey during 2010-2014 was supported by multiple grants from the US National Cancer Institute including R01 CA100362, P01 CA138389, and P01 CA138389-06S1. Additional grant support was provided by the Canadian Institutes of Health Research (79551, 115016, and FDN-14877), and National Health and Medical Research Council of Australia (265903, 450110, APP1005922). Work conducted for this article was also partially supported by grants from the US National Cancer Institute (P01 CA200512) and National Health and Medical Research Council of Australia (APP1106451). AM and SCH are members of the UK Centre for Tobacco & Alcohol Studies, a UK Clinical Research Collaboration Public Health Research: Centre of Excellence whose work is supported by funding from the Medical Research Council, British Heart Foundation, Economic and Social Research Council, and the National Institute for Health Research under the auspices of the UK Clinical Research Collaboration (MR/K023195/1). AM and SCH are also funded by Cancer Research UK (C25586/A19540). GTF is supported by a Senior Investigator Award from the Ontario Institute for Cancer Research and a Prevention Scientist Award from the Canadian Cancer Society Research Institute. SMLG is supported by a Canadian Cancer Society Career Development Award in Prevention.